Tag: Blood Disorders
Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia
Responses for patients with myelofibrosis, essential thrombocythemia
Blood Test Predicts Relapse in Early-Stage Breast Cancer
Circulating tumor DNA analysis spots stray cells months before scans detect recurrence
Daratumumab Monotherapy Promising for Multiple Myeloma
Findings in a phase 1-2 study of patients with relapsed myeloma or relapsed/refractory myeloma
Promacta Approval Expanded for Children With Chronic ITP
Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura
Revised Staging System Prognostic for Multiple Myeloma
ISS plus chromosomal abnormalities, lactate dehydrogenase prognostic in multiple myeloma
ASCO Updates Guidelines for Colony-Stimulating Factor Use
Special article updates 2006 guidelines, including addition of tbo-filgrastim and filgrastim-sndz
Extreme Exercising Without Training May Trigger Sepsis
Exercise over a prolonged period of time allows endotoxins in the gut to leak into the bloodstream
Idarucizumab Deemed Effective for Dabigatran Reversal
Findings among patients with serious bleeding or who require an urgent procedure
ASCO: Elotuzumab Shows Benefit in Multiple Myeloma
Survival gains when elotuzumab was added to treatment
High-Value Research of 2014 Presented for Hematology
Author summarizes 2014 studies that are highly relevant to hematology
